MedPath
HSA Approval

ACNOTIN 20

SIN13051P

ACNOTIN 20

ACNOTIN 20

March 4, 2005

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

D10BA01

isotretinoin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Mega Lifesciences Public Company Limited

Active Ingredients

ISOTRETINOIN

20 mg

Isotretinoin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACNOTIN 20 - HSA Approval | MedPath